Synonym
ST-148; ST 148; ST148;
IUPAC/Chemical Name
3-Amino-6,7,8,9-tetrahydro-5H-1-thia-10-aza-cyclohepta[f]indene-2-carboxylic acid (5-phenyl-[1,3,4]thiadiazol-2-yl)-amide
InChi Key
FGRXYHXHXBKKAK-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H19N5OS2/c22-16-14-11-13-9-5-2-6-10-15(13)23-20(14)28-17(16)18(27)24-21-26-25-19(29-21)12-7-3-1-4-8-12/h1,3-4,7-8,11H,2,5-6,9-10,22H2,(H,24,26,27)
SMILES Code
O=C(C1=C(N)C2=CC3=C(CCCCC3)N=C2S1)NC4=NN=C(C5=CC=CC=C5)S4
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
421.53
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Finkelman MD, Jamison RN, Kulich RJ, Butler SF, Jackson WC, Smits N, Weiner SG. Cross-validation of short forms of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R). Drug Alcohol Depend. 2017 Sep 1;178:94-100. doi: 10.1016/j.drugalcdep.2017.04.016. Epub 2017 Jun 13. PubMed PMID: 28645065.
2: Scaturro P, Trist IM, Paul D, Kumar A, Acosta EG, Byrd CM, Jordan R, Brancale A, Bartenschlager R. Characterization of the mode of action of a potent dengue virus capsid inhibitor. J Virol. 2014 Oct;88(19):11540-55. doi: 10.1128/JVI.01745-14. Epub 2014 Jul 23. PubMed PMID: 25056895; PubMed Central PMCID: PMC4178822.
3: Byrd CM, Dai D, Grosenbach DW, Berhanu A, Jones KF, Cardwell KB, Schneider C, Wineinger KA, Page JM, Harver C, Stavale E, Tyavanagimatt S, Stone MA, Bartenschlager R, Scaturro P, Hruby DE, Jordan R. A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother. 2013 Jan;57(1):15-25. doi: 10.1128/AAC.01429-12. Epub 2012 Oct 15. PubMed PMID: 23070172; PubMed Central PMCID: PMC3535982.
4: Weber B, Schlicker E, Sokoloff P, Stark H. Identification of the dopamine autoreceptor in the guinea-pig retina as D(2) receptor using novel subtype-selective antagonists. Br J Pharmacol. 2001 Aug;133(8):1243-8. PubMed PMID: 11498509; PubMed Central PMCID: PMC1621144.
5: Ang HH, Cheang HS. Quantitative assessment of Malaysian plasmodium falciparum clones to schizontocidal drugs before and after cryopreservation. Chemotherapy. 1999 Nov-Dec;45(6):446-51. PubMed PMID: 10567775.
6: Ang HH, Chan KL, Mak JW. Susceptibility of Malaysian Plasmodium falciparum isolates to antimalarial drugs after cryopreservation and 12 months of continuous in vitro culture. Chemotherapy. 1997 Sep-Oct;43(5):311-5. PubMed PMID: 9309363.
7: Ang HH, Chan KL, Mak JW. Electrophoretic variations of peptidase E (PEPE) in characterizing clones and isolates of Plasmodium falciparum from different geographical areas. Folia Parasitol (Praha). 1997;44(2):128-30. PubMed PMID: 9269721.
8: Ang HH, Chan KL, Mak JW. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique. J Parasitol. 1996 Dec;82(6):1029-31. PubMed PMID: 8973418.
